Current Allergy and Asthma Reports

, Volume 10, Issue 2, pp 84–91 | Cite as

Vasomotor Rhinitis



Vasomotor rhinitis is a common disorder that is seen routinely in allergy practice. It affects millions of Americans and results in significant morbidity. The pathophysiology of this complex heterogeneous disorder is unknown, but we are making advances in this regard. Symptoms and signs can closely resemble those of allergic rhinitis and can be difficult to differentiate from those resulting from allergy. A careful history, physical examination, and diagnostic testing help clinicians arrive at a definitive diagnosis, but treatment can be challenging. Therapy should be based on the presenting symptoms of vasomotor rhinitis. Combination therapy with topical corticosteroids and azelastine is useful. However, in patients whose predominant symptom is rhinorrhea, use of atopical anticholinergic agents can be quite useful. Up-to-date pathogenesis, epidemiology, diagnosis, and treatment approaches are discussed in this review.


Rhinitis Vasmotor rhinitis Non allergic rhinitis Rhinitis treatment 


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    •• Kaliner MA, Farrar JR: Consensus review and definition of nonallergic rhinitis with a focus on vasomotor rhinitis, proposed to be known henceforth as non allergic rhinopathy: part 1. Introduction. World Allergy Organ J 2009, 2:155. A complete and comprehensive review of chronic nonallergic rhinitis consisting of several articles published online in this journal begins with this article.CrossRefGoogle Scholar
  2. 2.
    •• Wallace DV, Dykewicz MS: The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008, 122:S1–S84. This is a consensus, evidence-based document published as a guideline and prepared as a joint effort of the American Academy of Allergy, Asthma, and Immunology and American College of Allergy, Asthma, and Immunology.CrossRefPubMedGoogle Scholar
  3. 3.
    Blom HM, Godthelp T, Fokkens WJ, et al.: Mast cells, eosinophils and IgE-positive cellsin nasal mucosa of patients with vasomotor rhinitis. An immunohistochemical study. Eur Arch Otorhinolaryngol 1995, 252(Suppl 1):S33–S39.CrossRefPubMedGoogle Scholar
  4. 4.
    Powe DG, Huskisson RS, Carney AS, et al.: Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy 2001, 31:864–872.CrossRefPubMedGoogle Scholar
  5. 5.
    Zeiger RS: Differential diagnosis and classification in rhinosinusitis. In Nasal Manifestations of Systemic Diseases. Edited by Schatz M, Zeiger RS. Providence, RI: Oceanside Publications; 1991:3–20.Google Scholar
  6. 6.
    Kaliner MA: Classification of non-allergic rhinitis syndromes with a focus on vasomotor rhinitis, proposed to be known henceforth as nonallergic rhinopathy. World Allergy Organ J 2009, 2:98–101.CrossRefGoogle Scholar
  7. 7.
    Middleton E Jr: Chronic rhinitis in adults. J Allergy Clin Immunol 1988, 81:971–975.CrossRefPubMedGoogle Scholar
  8. 8.
    Dykewicz MS, Fineman S, Skoner DP: Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol 1998, 81:478–518.CrossRefPubMedGoogle Scholar
  9. 9.
    Mullarkey MF, Hill JS, Webb DR: Allergic and nonallergic rhinitis: their characterization with attention to the meaning of nasal eosinophilia. J Allergy Clin Immunol 1980, 65:122–126.CrossRefPubMedGoogle Scholar
  10. 10.
    Enberg RN: Perennial nonallergic rhinitis: a retrospective review. Ann Allergy 1989, 63:513–516.PubMedGoogle Scholar
  11. 11.
    Togias A: Age relationships and clinical features of nonallergic rhinitis. J Allergy Clin Immunol 1990, 85:182.Google Scholar
  12. 12.
    Settipane RA, Lieberman P: Update on nonallergic rhinitis. Ann Allergy Asthma Immunol 2001, 86:494–507.CrossRefPubMedGoogle Scholar
  13. 13.
    Leynaert B, Bousquet J, Neukirch C, et al.: Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects. Results from the European Community Respiratory Health Survey. J Allergy Clin Immunol 1999, 104:301–304.CrossRefPubMedGoogle Scholar
  14. 14.
    Mercer MJ, van der Linde GP, Joubert G: Rhinitis (allergic and nonallergic) in an atopic pediatric referral population in the grasslands of inland South Africa. Ann Allergy Asthma Immunol 1002, 89:503–512.CrossRefGoogle Scholar
  15. 15.
    Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J: Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 2006, 61:693–698.CrossRefPubMedGoogle Scholar
  16. 16.
    Molgaard E, Thomsen SF, Lund T, et al.: Difference between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy 2007, 62:1033–1037.CrossRefPubMedGoogle Scholar
  17. 17.
    • Schatz M, Zeiger RS, Chen W, et al.: The burden of rhinitis in a managed care organization. Ann Allergy Asthma Immunol 2008, 101:240–247. This was an excellent review of the epidemiology of rhinitis and its burden on society.CrossRefPubMedGoogle Scholar
  18. 18.
    Berger WE, Schonfeld JE: Nonallergic rhinitis in children. Curr Allergy Asthma Rep 2007, 7:112–116.CrossRefPubMedGoogle Scholar
  19. 19.
    Settipane GA, Klein DE: Nonallergic rhinitis: demography of eosinophils in nasal smear, blood total eosinophil counts and IgE levels. N Engl Reg Allergy Proc 1985, 6:363–366.CrossRefPubMedGoogle Scholar
  20. 20.
    Settipane RA: Epidemiology of vasomotor rhinitis. World Allergy Organ J 2009, 2:115–118.CrossRefGoogle Scholar
  21. 21.
    Baraniuk JN: Pathogenic mechanisms of idiopathic nonallergic rhinitis. World Allergy Organ J 2009, 2:106–114.CrossRefGoogle Scholar
  22. 22.
    Powe DG, Jagger C, Kleinjian A, et al.: ‘Entopy’ localized mucosal allergic disease in the absence of systemic responses for atopy. Clin Exp Allergy 2003, 33:1374–1379.CrossRefPubMedGoogle Scholar
  23. 23.
    van Rijswisk JB, Blom HM, Kleinjan A, et al.: Inflammatory cells seems not to be involved in idiopathic inflammatory rhinitis. Rhinology 2003, 41:25–30.Google Scholar
  24. 24.
    Rondon C, Romero JJ, Lopez S, et al.: Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol 2007, 119:899–905.CrossRefPubMedGoogle Scholar
  25. 25.
    Powe DG, Huskisson RS, Carney AS, et al.: Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy 2001, 31:864–872.CrossRefPubMedGoogle Scholar
  26. 26.
    Smurthwaite L, Walker SN, Wilson DR, et al.: Persistent IgE synthesis in the nasal mucosa of hay fever patients. Eur J Immunol 2001, 31:3422–3431.CrossRefPubMedGoogle Scholar
  27. 27.
    Smurthwaite L, Durham SR: Local IgE synthesis in allergic rhinitis and asthma. Curr Allergy Asthma Rep 2002, 2:231–238.CrossRefPubMedGoogle Scholar
  28. 28.
    Wierzbicki DA, Majumdar AR, Schull DE, Khan DA: Multiallergen nasal challenges in nonallergic rhinitis. Ann Allergy Asthma Immunol 2008, 100:533–537.CrossRefPubMedGoogle Scholar
  29. 29.
    • Khan DA: Allergic rhinitis with negative skin tests: does it exist? Allergy Asthma Proc 2009, 30:465–469. This is a critical look at the concept of entopy as it applies to the pathogenesis of nonallergic rhinitis.CrossRefPubMedGoogle Scholar
  30. 30.
    Dray A, Urban L, Dickenson A: Pharmacology of chronic pain. Curr Opin Allergy Clin Immunol 2002, 2:11–19.CrossRefGoogle Scholar
  31. 31.
    Belmonte C, Viana F: Molecular and cellular limits to somatosensory specificity. Mol Pain 2008, 4:14.CrossRefPubMedGoogle Scholar
  32. 32.
    Blom HM, Van Rijswijk JB, Garrelds IM, et al.: Intranasal capsaicin is efficacious in nonallergic noninfectious perennial rhinitis. A placebo controlled study. Clin Exp Allergy 1997, 27:796–801.CrossRefPubMedGoogle Scholar
  33. 33.
    Baraniuk JN, Peterie KN, Le U, et al.: Neuropathology in rhinosinusitis. Am J Respir Crit Care Med 2005, 171:5–11.CrossRefPubMedGoogle Scholar
  34. 34.
    Naranch K, Park YJ, Repka-Ramirez MS, et al.: A tender sinus does not always mean sinusitis. Otolaryngol Head Neck Surg 2002, 127:387–397.CrossRefPubMedGoogle Scholar
  35. 35.
    Braat JP, Mulder PG, Fokkens WJ, et al.: Intranasal cold dry air is superior to histamine challenge in determining the presence and degree of nasal hyperreactivity to nonallergic noninfectious perennial rhinitis. Am J Respir Crit Care Med 1998, 157:1748–1755.PubMedGoogle Scholar
  36. 36.
    van Rijswijk JB, Blom HM, Fokkens WJ: Idiopathic rhinitis, the ongoing quest. Allergy 2005, 60:1471–1481.CrossRefPubMedGoogle Scholar
  37. 37.
    Silvers WS: The skier‘s nose: a model of cold induced rhinorrhea. Ann Allergy 1991, 67:32–36.PubMedGoogle Scholar
  38. 38.
    Waibel KH, Chang C: Prevalence and food avoidance behaviors for gustatory rhinitis. Ann Allergy Asthma Immunol 2008, 100:200–205.CrossRefPubMedGoogle Scholar
  39. 39.
    Jaradeh SS, Smith TL, Torrico L, et al.: Autonomic nervous system evaluation of patients with vasomotor rhinitis. Laryngoscope 2000, 110:1828–1831.CrossRefPubMedGoogle Scholar
  40. 40.
    Segal S, Shlamkovitch N, Eviatar E, et al.: Vasomotor rhinitis following trauma to the nose. Ann Otol Rhinol Laryngol 1999, 108:208–210.PubMedGoogle Scholar
  41. 41.
    Jones NS: Midfacial segment pain: implications for rhinitis and sinusitis. Curr Allergy Asthma Rep 2004, 4:187–192.CrossRefPubMedGoogle Scholar
  42. 42.
    Lindberg S, Malm L: Comparison of allergic rhinitis and vasomotor rhinitis patients on the basis of a computer questionnaire. Allergy 1993, 48:602–607.CrossRefPubMedGoogle Scholar
  43. 43.
    Wedback A, Enbom H, Eriksson NE, et al.: Seasonal nonallergic rhinitis (SNAR)—a new disease entity? A clinical and immunological comparison between SNAR, seasonal allergic rhinitis and persistent nonallergic rhinitis. Rhinology 2005, 43:86–92.PubMedGoogle Scholar
  44. 44.
    Brandt A, Bernstein JA: Questionnaire evaluation and risk factor identification for nonallergic vasomotor rhinitis. Ann Allergy Asthma Immunol 2006, 96:526–532.CrossRefPubMedGoogle Scholar
  45. 45.
    Kaliner MA, Baraniuk JN, Benninger M, et al.: Consensus definition of nonallergic rhinopathy, previously referred to as vasomotor rhinitis, nonallergic rhinitis, and/or idiopathic rhinitis. World Allergy Organ J 2009, 2:119–120.CrossRefGoogle Scholar
  46. 46.
    Bernstein IL, Li JT, Bernstein DI, et al.: Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol 2008, 100(Suppl 3):S1–S148.Google Scholar
  47. 47.
    Blom HM, Godthelp T, Fokkens WJ, et al.: The effect of nasal steroid aqueous spray on nasal complaint scores and cellular infiltrates in the nasal mucosa of patients with nonallergic and noninfectious perennial rhinitis. J Allergy Clin Immunol 1997, 100:739–747.CrossRefPubMedGoogle Scholar
  48. 48.
    Philip G, Togias AG: Nonallergic rhinitis. Pathophysiology and models for study. Eur Arch Otorhinolaryngol 1995, 252(Suppl 1):S27–S32.CrossRefGoogle Scholar
  49. 49.
    Wight RG, Jones AS, Beckingham E, et al.: A double blind comparison of intranasal budesonide 400 micrograms and 800 micrograms in perennial rhinitis. Clin Otolaryngol 1992, 17:354–358.CrossRefPubMedGoogle Scholar
  50. 50.
    Small P, Black M, Frenkiel S: Effects of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol 1982, 70:178–182.CrossRefPubMedGoogle Scholar
  51. 51.
    Scadding GK, Lund VJ, Jacques LA, Richards DH: A placebo controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and nonallergic perennial rhinitis. Clin Exp Allergy 1995, 25:737–743.CrossRefPubMedGoogle Scholar
  52. 52.
    Webb DR, Meltzer EO, Finn AF Jr, et al.: Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia. Ann Allergy Asthma Immunol 2002, 88:385–390.CrossRefPubMedGoogle Scholar
  53. 53.
    Banov CH, Lieberman P: Efficacy of azelastine nasal spray in the treatment of vasomotor rhinitis (perennial nonallergic rhinitis). Ann Allergy Asthma Immunol 2001, 86:28–35.CrossRefPubMedGoogle Scholar
  54. 54.
    Lieberman P, Kaliner MA, Wheeler WJ: Open label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis. Curr Med Res Opin 2005, 21:611–618.CrossRefPubMedGoogle Scholar
  55. 55.
    Ciprandi G, Pronzato C, Passalacqua G, et al.: Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity. J Allergy Clin Immunol 1996, 98:1088–1096.CrossRefPubMedGoogle Scholar
  56. 56.
    Yoneda K, Yamamoto T, Ueta E, Osaki T: Suppression by azelastine hydrochloride of NF-kappa B activation involved in generation of cytokines and nitric oxides. Jpn J Pharmacol 1997, 73:145–153.CrossRefPubMedGoogle Scholar
  57. 57.
    Grossman J, Banov C, Boggs P, et al.: Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial nonallergic rhinitis, alone and in combination with other perennial rhinitis medications. J Allergy Clin Immunol 1995, 95:1123–1127.CrossRefPubMedGoogle Scholar
  58. 58.
    Bronsky EA, Druce H, Findlay SR, et al.: A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. J Allergy Clin Immunol 1995, 95:1117–1122.CrossRefPubMedGoogle Scholar
  59. 59.
    • Horak F, Zieglmayer P, Zieglmayer R, et al.: A placebo controlled study of the nasal decongestant effect of phenylephrine and pseudoephedrine in the Vienna challenge chamber. Ann Allergy Asthma 2009, 102:116–120. This was an objective investigation of the effects of nasal decongestants.CrossRefGoogle Scholar
  60. 60.
    Harvey R, Hannan SA, Badia L, et al.: Nasal saline irrigations for the symptoms of chronic rhinosinusitis. Cochrane Database Syst Rev 2007, 3:CD006394.Google Scholar
  61. 61.
    Tomooka LT, Murphy C, Davidson TM: Clinical study and literature review of nasal irrigation. Laryngoscope 2000, 110:1189–1193.CrossRefPubMedGoogle Scholar
  62. 62.
    Pynnonen MA, Mukerji, SS, Kim HM, et al.: Nasal saline for chronic sinonasal symptoms: a randomized controlled trial. Arch Otolaryngol Head Neck Surg 2007, 133:1115–1120.CrossRefPubMedGoogle Scholar
  63. 63.
    Mladina R, Risavi R, Subaric M: CO2 laser anterior turbinectomy in the treatment of nonallergic vasomotor rhinopathy. A prospective study upon 78 patients. Rhinology 1991, 29:267–271.PubMedGoogle Scholar
  64. 64.
    el-Guindy A: Endoscopic transseptal vidian neurectomy. Arch Otolaryngol Head Neck Surg 1994, 120:1347–1351.Google Scholar
  65. 65.
    Fernades CM: Bilateral transnasal vidian neurectomy in the management of chronic rhinitis. J Laryngol Otol 1994, 108:569–573.Google Scholar
  66. 66.
    Prasanna A, Murthy PS: Vasomotor rhinitis and sphenopalatine ganglion block. J Pain Symptom Manage 1997, 13:332–338.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Allergy & Asthma CareGermantownUSA

Personalised recommendations